Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: Alquemie, 19 Jun 2024 17:48
Last post: Dougie999, 21 Jun 2024 18:04
Thank you for sharing Bignose. ridiculous that investors need to go directly questioning the people involved as we are left in the dark
Morning bignose. thanks for that. perhaps the civility of the response is indicative of a tacit acceptance of the criticism.as you say,obviously that acceptance(if indeed there is such)will never be acknowledged explicitly. perfectly valid questions re can sales in the context given.not holding my breath for a detailed response.good of you to press these issues.
Well I did get an unexpected response from Jamie which actually was surprisingly civil given my content.
Anyway he did point out that the non agreement statement was included in the Chairmans statement in the AR, however. As I responded and pointed out to him, it should have been included in the AFR since that document paints a totally different picture as to the progress being made and possible future sp impact.
He obviously has and will not admit any wrongdoing.
In addiiton I have asked for more info on can sales given they have stated, after Recordatis resumption of sales, that 30k cans every 5 months is positive which is nonsense. Especially when PSNW upscalied production to 50k cans every 6 to 8 weeks and back then a can was 100EU/can compared to the current 40EU/can. He has tried to allude to the fact that its considered as insider information, however. I have pointed out that as he has stated the manufacturer can produce 5mill cans/year and that sales would be exponential, surely its time to provide an update on figures as 30k cans/5months is not positive an any way.
Anyway, will be interesting to see if he responds.
Not in my nature to say "I told you so", but hey...I told you that this was dead last February when the Phase II data was made public. Caveat emptor, Mr Praline.
Now let's see...what else might they be gaslighting you poor old shareholders about? Shortcomings in the NMPA dossier? Perhaps something to do with the requirement to include measurement of the genotoxic metabolites 2,6-dimethylaniline and o-toluidine in the Pk/tox studies? As expected, no issues in male or female subjects, but bless me, manufacture and specification have changed since Oompa Loompa clinical supply and of course , there's no genotox data for the Made in Italy version.
Hmm...wonder if the NMPA will let this slide...? And 14 months on, still no release of the allegedly stellar Phase III data.
Tick...tock...
They owe an explanation let’s be honest. This isn’t the first time we have been severely let down
Last post: The.Italian, 14 Jun 2024 15:30
Well i realise they have to report it in the detailed terms used but really the pitiful amount involved hardly justifies the time taken to produce the formal announcement. perfectly fair questions raised by you,bignose. the only consolation is that they will no longer be able to use the ludicrous excuse of"curating legacy assets" to justify use of time by BOD.
hard to believe there is still no china news. absolute shambles!
Wel…..that’s absolute rubbish. The last thing the company needs are more worthless investments
The Directors (including the independent non-executive Directors) are of the view that the Disposal represents a good opportunity to increase the liquid cash position of the Company, deleverage its balance sheet and put the Company in a better and more flexible financial position to take advantage of any investment opportunities should they arise.
And
It is the intention of the Company to use the proceeds from the Disposal to help fund corporate and working capital expenses, which mainly includes general administrative expenses and research & development expenses.
Does that mean the company is burning through the loan at an accelerated rate. Once again misleading and no transparency.
So, they’ve now sold the remaining DVP shares.
Why didn’t they just sell them all earlier when the DVP sp was higher ? It’s on a Low at this moment in time.
And why now given they have a loan from Jim supposedly covering their cost for the next 12 months.
Why do they need the money now ?
Morning bignose.yes all very odd.makes no sense to me,but pleased to see it if only to savour for a moment a significant percentage gain.news perhaps about to land?
Up 25% on a single lot buy (10k shares and about 750gpb). Who would buy a single lot at a25% premium unless they had surely heard something ? Particularly since it can go down just as quickly on a single lot sell. A large risk to take unless the investor knows somehting ?
Agreed bignose.whilst i'm happy to accept that things always take longer than one hopes, the lesson from Fum/Haleon is no doubt that things don't happen overnight. (i found some of the comments on Fum suggesting the BOD had been remiss in agreeing a deal with one of the largest consumer healthcare companies in the world, just because they hadn't launched yet, frankly risible). the difference of course is that FUm (at least since dec 2019) don't have a history of repeated missed deadlines and unmet promises, as by and large they have kept to their stated intentions etc. regent on the other hand.....!!! oh we'll tomorrow is another day.
Morning The.Italian,
Yes, it is becoming a little concerning, particulalry since it will be soon be 9 months from when the submission was supposed to happen and we then still have another 12 months for the approval and then another possible 12 months before Wangbang get it on the shelves (think Haleon/Eroxon which has so far taken nearly 11 months without any news of a product launch), although one would think they will have already sorted their logisitcs out beforehand.
Morning bignose.yes, the continuing delay re china progress is very puzzling and concerning. despite the recent volatility, trading volumes in value terms have remained minuscule, so no real indication of interest either way. fingers continuing to be crossed.
Started: The.Italian, 31 May 2024 19:40
Last post: Alquemie, 3 Jun 2024 14:39
I sincerely hope that "Today's runs" is not a health report.
And yes, auditors consider RPG estimates of asset value to exceed what a purchaser might reasonably acquire the assets for, fair value being derived from future DCFs.
Curious as to why this has appeared long after the auditors signed off on the Annual Report- did they miss just how vigorously RPG have been jiggling the parrot, or is it only retrospective posterior protection? Still, you have to admire RPG's brass neck in trying to get away with a fantasy US milestone...cheeky...although they did get away with a fantasy IA valuation for the best part of a decade. Crystal clear that there's no expectation of a money fountain.
The reduction in the useful life of DLI intangible assets is puzzling, with the revised forecast assigning a useful life of just four years. This suggests that on acquisition, only licence(s) with In Silico were assigned to RPG, but no patent assignment (quick check indicates that IP remains assigned to In Silico, expiry many years away). I would have thought the licence term/useful life would have been at least 10 years from acquisition, not that it makes a difference in the scheme of things.
Going concern issue now looking more like a going...going...gone... concern issue.
Not easy to follow for non accountancy minded people like me, but my take is the auditors felt the revenue forecasts for AI were overly optimistic in view of the actual revenue experience to date and in effect insisted on a full impairment. is this how other see it?
Last post: bignose58, 28 May 2024 12:52
Bothwell. If all goes well regarding Chinese approval and sales targets are met, it could well be another 18 to 24 months, since sales would be the main driver, although, that said. It could suddenly spike on approval announcement with a slow pullback in the following 6 months pending sales figures vs expectation. All speculation on my part, but is logical based on what w have seen b4.
Bignose, then profit!!! How long are you giving it to reach the market cap?
Yup. A market cap of around 185mill gbp or a little less, I would expect, will see most LTHs (those around at the PLE takeover) at breakeven. This is easily achievable and poss in the first year if the Chinese sales are as Wangbang predict.
Just checked 8HKD is breakeven for me after dilution. Long long way to go.
Too true,bignose,but if we did get some positive US news (huge if i know ) we should get some traction from that.
Started: Bothwell, 4 May 2024 09:47
Last post: Alquemie, 13 May 2024 18:27
My bad- that's the p value for global impression of severity, not bother. Latter given as a % recording a 1 point or greater improvement over baseline, and while twice as frequently recorded in the treatment group, still impossible to interpret in absence of objective treatment effect (moreover, may have involved only single treatment period encounter, and only 38 subjects on treatment. Even if there had been clear objective treatment difference, ITT population too small to support validation).
Bothwell, this certainly has the hallmarks of classic Gibson waffle, simply re-hashing past half-truths, and with lines lifted verbatim from past releases. Or has someone been helping you play with ChatGPT?
As for the PRO results "speaking for themselves", the published data screams "no significant difference in post-treatment IELT between treatment and placebo", a 50% placebo response versus 70% treatment response for subjective endpoints, and probably most damning of all with respect to PRO validation, no difference in global impression of change between treatment and placebo groups at end of treatment. True, the difference between means for Item 3 did reach significance (P = 0.0031), but impossible to interpret this in the absence of clear-cut objective and subjective treatment effects.
So, do you have the guts to look at the data (simple comparison of means is all that's needed), or too frightened to test faith with fact? Or why not cut through the waffle and ask outright "has the FDA accepted that the Phase II study data validates bother as an acceptable co-primary endpoint, and that the PEBEQ is now validated as an appropriate instrument"?
Yes bothwell that is the issue , we need massive growth for some long term investors to even get back to even. Then we would need another big growth period to make long term hold worthwhile. Lets hope they can deliver against the odds!
Dilution has killed our investment but also kept us alive. Need to get 20 x the current SP to get back to evens then make some money!!!! Still go six years!!!
If we require extra money then I do hope it is a loan as they now know they will get it back. Dilution would be terrible for us again.
Started: The.Italian, 30 Apr 2024 15:11
Last post: The.Italian, 30 Apr 2024 15:11
so april has passed with no china news.why would regent state on the 28th march that china submission expected by end of q1 (haven't checked the precise wording as can't be bothered,but you get the drift) if i said i was expecting something to happen in a couple of days or so's time i would be basing this on fairly reliable information,not just hope and guesswork! perhaps that explains why i'm not on the regent board.now utterly ****ed off with this farce!
Started: bignose58, 26 Apr 2024 08:51
Last post: Bothwell, 27 Apr 2024 10:19
Morning Bignose, thank you for getting in contact with the BoD and asking the correct questions. It really is a shambles that China isn’t further on and the US is not closer to completion. Can believe JM is just paying Jamie to do nothing. Dr Mike seems to have vanished off the scene. Dilution was a terrible for us private holders but good for the BoD. 2025 has now move to 2026. I finally have no confidence in the BOD had my investment has gone.
Well another new low today with a market cap of 9.33mil squid. Not bad for a company that has a needed product which has been on sale in Europe since Nov 2016......COUGH.
Started: The.Italian, 19 Apr 2024 12:40
Last post: bignose58, 19 Apr 2024 14:29
Certainly agree re the Chinese effort which seems to have stalled. Over 6 months delay with no real reason given as to why they keep missing dates, but then again, it is nothing new with RPG.
Well at least some activity at DLI
https://twitter.com/Deep_Longevity/status/1781211957413986356?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
nothing very significant of course,but at least some sign of life.
massively disappointing that no confirmation yet of chinese NDA submission.what is the problem with these people. so unprofessional!
Last post: The.Italian, 15 Apr 2024 09:52
Personally i'm surprised that it is still legal to sell bananas.! only a matter if time i expect.lol
Could you imagine how many people would be arrested today just for thinking that. A few years ago maybe, but certainly not today :-O
Hey darling, wanna see my new 64k banana.....lol
Morning bignose.well that is an interesting take on things.i certainly hope your interpretation is correct.fingers crossed as always.do you think Apple would have had the same degree of success is they had been called "Banana"? hey guys, come and see my new Banana, doesn't seem to have quite the right ring to it.lol
That should have been ‘unrecognised’. Typing on my iPad has always been a pain. The screen constantly refreshes due all the damned adverts. :-( sometimes I’ve even lost whole messages before being able to post. I give up in the end. I’d probably get more posted typing on a banana rather than my apple…..lol
Morning The.Italian,
With respect to the “significant and previously recognised demand”. The only thing I would write about that is. If Recordati didn’t see that, why would they spend so much time patently waiting for PSNW to solve the issue. Then get their own recommended manufacturer to sort it, unless they are really stupid, which, going by the companies progress year on year, would indicate otherwise.
Obviously only time will tell, but they certainly do give the impression that they still have (in the words of Charles Dickens) great expectations. ;-)
Started: bignose58, 12 Apr 2024 07:08
Last post: bignose58, 12 Apr 2024 07:08
I think we may start to see more share action and possibly volatility due to the impending Chinese NDA submission which is due any day now. Maybe even an announcement this evening (I'm only speculating on that since we are already a week behind)
Started: bignose58, 11 Apr 2024 10:30
Last post: bignose58, 11 Apr 2024 11:31
So, it started off...... A case of the invisible "f" :-)
So, it started of and held for the majority of the day at +11.11%, come the late afternoon and close, that was changed to a loss of -4.44. Certainly some antics going on.....lol
Started: The.Italian, 7 Apr 2024 14:17
Last post: bignose58, 10 Apr 2024 04:13
Bothwell,
I cannot help feel that the FDA process will take much longer than 2025. Firstly, according to the 2019 presentation, the FDA wants 172 subjects and given how long it has taken just to sort out 87 for phase 2, it could take 3 years before the NDA is submitted. Then there is the issue with manufacturer, which has not even been discussed and of course the pre launch marketing and distribution logistics. (Would they really only want to launch in one state ?).
With China it could be another 2 years before any income stream is seen since they have stated they intend to target 9mill subjects. That is going to require a production line which can produce at lease 300k cans/month and that's if they only intend to target 3.6mill sufferers.
Anyway, I did email the company and had a response a day later (As i wrote it pays to copy the big 3 -Jim/Jamie/Mike plus company secretary since they are then obliged to answer. as long as its not abusive which in my case needed a lot of restraint....lol).
Anyway, I'll post the response which does make for some interesting reading regarding finance requirements, although I have asked for further clarifications. It certainly reads as positive for Europe although I am still skeptical since we have heard it all before regarding timelines and what their future plans are.
I would love to retain your optimism bothwell but mine is long gone! It’s damage limitation at this point and I’m just hoping we can pull something back respectable . How can faith in this team still be here with what has gone on so far ?
I love the optimism even though it is, yet again, a significant distance way. At 90% underwater on this particular ‘money fountain’ I will be truly delighted if your optimistic prophecy materialises.
As I said a year or so ago, I have a feeling that 2025 is the year we will see the approval in the US complete and possibly a China at the beginning of 2025. Jim Mellon isn’t investing his millions in here to keep Jamie living he could just move him to another of his companies.
And of course a new low.
Started: bignose58, 8 Apr 2024 03:46
Last post: bignose58, 8 Apr 2024 03:46
Dougie, you've got to be joking, haven't you ?
They would expose themselves to much ridicule:
Not able to follow any of their timelines.
Not keeping shareholders sufficiently updated.
Have next to no transparency.
Continually providing misleading information.
Making bad investment decisions.
And
Totally demolishing shareholder investment.
Started: The.Italian, 4 Apr 2024 07:54
Last post: bignose58, 5 Apr 2024 10:22
It has happened before on a one lot buy or sell. Who knows the machinations of the MM's, although I don't think the lack of shares available is a reason given the MM's must be holding quite a few themselves now. Of course nothing like the liquidity last weeks annual results would have us believe.
Here a 10k, there a 10k, everywhere a 10k. Old Jim Mellon had a farm...E-I-E-I-O...lol
Why the 17% jump today.
Another tweet.presumably this is,or is part of,the new launch referred to in the results.nothing exciting,but just for info. https://twitter.com/Deep_Longevity/status/1775968994643562996?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
As I've commented before on the absence of any observable activity from dli for a considerable time,i should perhaps point out a tweet now,which is the first i think for 8/9 months. nothing of significance in itself, but at least a small sign of life
https://twitter.com/Deep_Longevity/status/1775596244968092123?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
Started: The.Italian, 29 Mar 2024 14:02
Last post: Bothwell, 31 Mar 2024 12:11
I think if Bignose or Italian asked some of their questions to Jim Mellon he would respond. The journey continues.
Whoops, apols for the typo. Even kids would be able to spell “capitals”…….derrr
Morning bignose.no problem.optimism is probably going it a bit.just relief that we did not get the bad news i was more than half expecting. i do of course,entirely agree with your post (and yours dougie,morning).the level of failure to advise as to promulgated developments is what you would expect from the most tin pot of aim companies and this is,despite its pitiful market cap,a main market company.anyway, question is will we get an announcement of china submission in next couple of weeks or silence and more delay?place your bets.
i hope mrs wylie,who is after all an innocent bystander in this sorry story, does not take offence at my poor attempt at humour,or else i shall also be exiled to the realm of those to whom no communication may be extended!
bothwell good morning to you also. i suspect we are,sadly, very far from mellon's thoughts now.
Maybe time to email Jim Mellon with your thoughts Bignose?
Why do they take offence when people question announcements that turn out to be incorrect? Constant delays , stating negotiations with certain territories are taking place for years but never a sign of a deal , unanswered communications showing no regard for investors.
of course investors will be angry when they feel they are given false hope , how could they expect anything else . Especially when share price has been obliterated through this time eroding any value for people.
Started: The.Italian, 25 Mar 2024 13:04
Last post: bignose58, 30 Mar 2024 05:54
Contd....
Then there was the Yooya fiasco, thankfully for us shareholders that didn't work out, but just reflect if it had. RPG wanted to pay 15mill usd for the company yet today its worth 1mill and last year closed shop in Japan, their supposed largest Asian market!!! RPG even stated in the fall out (remember the delay after delay after delay in getting the paperwork out) they had a more concrete investment, but gave no information and still have not clarified what that was all about (more likely a deflection from the embarrassment that Jim couldn't get his own way and would subsequently lose face).
Although I have written many times on the incompetence shown by the company, the above few examples are much much worse. How can a company publish such nonsense. How can a company still be run by a BOD and CEO who have absolutely no idea what is going on in their own company? It certainly seems Jim is totally oblivious to it as is shown by the rubbish he writes in the chairman's statement. Obviously he is being fed information he is supposed to write (that's if he actually does write anything).
I would have much rather they injected whatever cash they had into completing the FDA process instead of wasting money on the DBC and the DLI which have done nothing but cost shareholders dearly in money and consequently dilution and ultimately share price. I cannot see any income coming from the DLI to help alleviate the constant call for cash to keep the lights on particularly given they don't even announce when deals have been agreed which must mean they add up to next to nothing.
What's next ? who knows, but one thing is for sure if they don't sort their finances out for the next 3 years, come 2025 there may not be a company still around for us to discuss.
Although I am somewhat disappointed with respect to the Chinese submission as it now delays possible approval by 6 more months which will add time to when any income stream is seen. If they have not sorted a manufacturer till now, I would suspect they wont have sorted out distribution of product etc etc either, meaning that any income from the 9mill target sufferers may not happen till the end of 2025 or even the beginning of 2026 and that's when sales will start so RPG may not see any money till towards the end of 2026. If that is indeed the case and there is a good possibility that may happen, what money will the company run on ?
There may be a 4mill usd cash injection (less tax) triggered by the approval, but that surely will be used to offset any loan to get the company even to that point. Surely there will be a point when even Jim will get fed up loaning the company money and seeing no return. And then what about the monies needed for the phase III they cannot run a phase III without spending more money???
The FDA process has been nothing more than a car crash since the beginning. They wrote a lot about how it was there main objective however, its been nothing more than a disaster time after time. The original unambiguous FDA RNS in March 2014 with a follow up to say they expected approval by June/July 2017 was nothing more than lies. There has been no announcement as to why and what had changed changed. Instead all they did was kept giving excuses and delays. The phase II which was for only 100 subjects (I'll write that again 100 subjects !!!) has so far taken nearly 6 years from when shareholders were told recruitment had started, which it didn't. It then started at the end of Dec 2018 and was supposedly going to take 15 months and be completed by March 2020. 8 months into the study, we were told that the study would be completed 3 months early and be completed by the end of Dec 2020. Meaning that over 50% of subjects must have been processed, however. In Jan/Feb 2021 shareholders were informed only 15 subjects had been processed, which meant effectively the statement advising of a reduced timescale was nothing more than a known lie. And what about the licensee. The media were told in 2014 that the company was close to signing heads of terms with a US licensee. Yet still no reason was given as to why they walked away and stayed away.
Cans if……lol
Bothwell, I suspect the delay on the China submission is because they are now also sorting out a manufacturer. Why they didn’t do this a year ago beats me. Particularly since it’s very clear the new eu manufacturer will not be up to the job. China needs at least 1 mill can is they are targeting 9 mill sufferers in the first year.
I have sent him a couple of emails but no response from him. Usually very good.
Started: The.Italian, 23 Mar 2024 14:13
Last post: The.Italian, 23 Mar 2024 14:13
4 days until results.will there have been any progress? radio silence suggests not, but who knows!
Started: Bothwell, 8 Mar 2024 23:14
Last post: Bothwell, 21 Mar 2024 17:20
Date of Board Meeting
The board of directors (the “Board”) of Regent Pacific Group Limited
(the “Company”) announces that a meeting of the Board will be held on
Wednesday, 27 March 2024 for the purpose of, among other matters, approving
the final results of the Company and its subsidiaries for the year ended
31 December 2023 and its publication, and considering the recommendation on
the payment of a final dividend, if any.
I suppose “soon” could mean a lot of different things to regent. USA approval and more license agreements around the globe have been close for 10 years according to announcements
Same "friend" that told you China and the US are "going to happen"? And is that friend in the room with you now?
I was told soon…
Until you posted that, I was not expecting anything apart from what would be included in the year end results. Meaning nothing positive since they surely would have to announce any positive news as they have done all previous years.
But as I also wrote. Since they own nigh on 60% of the shares and probably have already informed those of importance, the average PI will not get to know until the said results. Just my opinion of course, but it certainly appears to be going that way.
Started: ripley94, 28 Nov 2022 22:32
Last post: bignose58, 8 Mar 2024 12:37
Who are Endurance RP anyway ???
Of course that should be Q3 2024.....derrr.
Anyone still signing cheques and putting last years date......Ahhh but then again, what are cheques anyway.... lol
I certainly would like to know where they will be getting the money from to bring this to fruition. Q3 2023 maybe only 6 months away (the company should then receive 4mill usd less taxes) but as far as I can see, there is no honey left in the pot.
I also notice from the last years mid year results that they had about 18 people on the books who need paying as well as the building rentals in HK and the UK.
Yes and this was released on 17 April 2023…….
Yes bothwell, painful performance when you read back the enthusiasm in the previous announcements . Needing a drastic change or some honesty about what is going on
Started: Keithbfk, 5 Mar 2024 20:57
Last post: Alquemie, 6 Mar 2024 14:04
Heh..that's "happy ex-investor" (admittedly a long time ago). And thank you for "erudite".
Graced with a quietly knowing smile, rather than a smirk, although with the occasional hint of smugness. I do look forward to a few hearty belly laughs on reading the next company update. Parrot-jiggling at its finest.
Send it to Jim and copy Jamie and the company secretary. You are more likely to get a response.
Jim doesn't necessarily always respond, but Jamie usually does after being told by Jim to pull his finger out.
That's from my past experience.
Of course, if you add that JG and the BOD are all incompetent, that will surely get JG's hackles up and he will more than likely respond and probably all in capitals......lol
Sent email to Jamie and Dr Mike a number of weeks ago and no response. They would always respond before.
At least we have one happy non investor who has always displayed erudite and informative negative comments. Always accompanied with a slight smirk me thinks.
Last post: Alquemie, 5 Mar 2024 17:33
What the f**k happened to my capitalisation?
"sell the product outright"...might be difficult when rpg don't have anything to sell. as stated multoties ante, no licensable or transferable intellectual property or commercial protection exists anywhere in the world.
past licences have been simple grants of commercial rights to an approved product. recordati is the de facto mah in europe (and owner of the fortacin trademark), and manufacturing know-how, if any, belongs to them and/or their subcontractor. in the increasingly unlikely event of approval in china (submission stimmied by historical cmc issues, a phantom reference product, and perhaps iffy data and cold feet over market potential), fosun would be the domestic mah and own the registration package.
so, what is in the ple lucky bag? an ind and clinical data package kicked into the long grass by the fda nearly 15 years ago, phase ii pilot data which failed to show any difference between treatment and placebo, the *** end of the recordati agreement, oh, and the orient europharma agreement, although hard to expect a royalty when you can't supply product. and of course that well known senstend trademark...
"remarkable bird, the norwegian blue... beautiful plumage!!
Fair enough bignose. all water under the bridge as they say. been out in the garden this morning spreading some manure ,which in the circumstances here seems very apposite. not sure what brand it was, but something like "mellon's magic" i think! gla.
Morning The.Italian. Not wanting to contradict, but for clarification. The listing was worth 40mill GBP before several dilutions. 40 cents today is, well. A lot lot less than the 40Mill GBP (or was it USD ?....makes no difference still a lot less.). :-)
Morning keith. looks like we are all singing pretty much off the same song sheet. doubt there is much chance of anyone seeking to acquire fortacin. does DLI have any value? probably not. still inclined to think mellon may seek to take it private.no doubt we all recall the assertions that the listing alone was worth 40 cents. what a load of nonsense that was.
Last post: The.Italian, 24 Feb 2024 09:40
Yes,thanks for those bothwell.dont think I've seen them before.serves to highlight the frustration at not having heard anything since end of august financials, when they said they were hoping for SPA approval by end of 2023. obviously they haven't got it as they would have announced it. if no prospect now of getting it they need to come clean and say so.
Thanks for sharing bothwell. For the last 8 years it’s been .. next year will be the year. Continuous cycle of delaying ! One day it may well be a good investment but for who? For investors already massively down it would take a big turn around. Also never understand why the chairman does not bring attention to regent at his master investor events.
Started: The.Italian, 21 Feb 2024 11:33
Last post: The.Italian, 21 Feb 2024 11:33
Morning bignose.year end results on 29th march last year,so not that long to go now,before some news to end this astonishing period of silence. i hope they don't just trot out the old tropes of continuing discussions with FDA etc.you would think they will have to provide some real updates as to what (if anything ) is happening,but with mellon and co being in total control i wouldn't bet on it.
Started: The.Italian, 20 Feb 2024 09:13
Last post: bignose58, 21 Feb 2024 10:25
There are probably 2 good reasons….. apols for the typo ;-)
So….If or when the patent runs out, will Recordati renegotiate a contract or will the existing contract have some clause already included, although I would suspect there is already some a definitive contact duration with clauses for continuation. I wonder if there was even a clause for them to apply for the OTC approval. Not sure if they would even consider renewing given how bad sales have been, although there is probably 2 good reasons to continue. Getting a local Italian manufacturer and obtaining OTC approval which cost both time and money. I wonder what their long term plan is?
FFS...how many more times?
Patent coverage expired in all territories in 2016 (and in the US in 2014). SPCs granted in a few European countries post-approval, all since expired.
Value of Fortacin as an intangible asset was based on the EMA 10 year market exclusivity which expired November 2023, along with some made-up fluff about revenue in other territories.
With no existent IP or other commercial protection in any territory, no need for amortization charge. Carrying value negligible, since only basis can be the NPV of the tail end of the Recordati agreement (less than four years away), Orient Europharma sales (if they ever get product- last imported batch expired Jan 2023), and risk-adjusted NPV for China (which I would not count on...).
Posts crossed. not sure there are any optimists left,but it's see what happens.
Morning bignose. yes finally. not sure about the implications of the end of the amortisation period.may make us look better in accounting terms,but the reality of no income is what matters.clearly no appreciable income (apart from the tax credit) in the period, as it would have been mentioned.there was no operational update with the PW last time either, but if there had been any good news i think they would have announced it. not looking good im afraid.